Delivery Order SPE2DB20D1004-SPE2DB25FNHRU

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,306.78 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, with an ultimate completion date of April 14, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This is a $22,547.56 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product, with a period of performance through March 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,515.47 order is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, with a performance period extending to May 9, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which provides a...
This is a $5,394.60 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a period of performance through February 26, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This is a $1,611.65 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 9, 2025 and was awarded on April 8, 2025. This delivery order is part of a larger Indefinite Delivery...
This is a $4,863.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is to provide ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, with a period of performance through May 30, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp is the prime contractor, and this order is associated with the company's $999,999,999.00 Indefinite...
This is a $9,408.33 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This is a $12,161.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a period of performance through May 28, 2025. The contract is not set-aside and was awarded as an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a $1,595.52 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a $5,434.49 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a period of performance through June 6, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNHRU
    Delivery Order

This is a $5,111.94 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of June 12, 2025. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, supplies a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/10/25, 10:02 AM